Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

A patient's grey hair regained color during treatment with adalimumab.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Social isolation makes rats more sensitive to alcohol's effects on the brain.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Targeting specific T cells may help treat alopecia areata.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Ferric carboxymaltose effectively improved iron deficiency anemia symptoms and increased hemoglobin and ferritin levels.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.